|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12N 5/0784 | (2010.01) |
| C12N2506/11 | (2013.01) | ||
| C12N 5/24 | (2006.01) | ||
| C12N 5/064 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61K 39/00 | (2006.01) | ||
| A61K2239/38 | (2023.05) | ||
| A61K 35/14 | (2015.01) | ||
| C12N 5/0639 | (2013.01) | ||
| A61K 40/19 | (2025.01) | ||
| A61K 40/24 | (2025.01) | ||
| A61K 40/42 | (2025.01) |
| (11) | Patento numeris | 3317403 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16818706.0 |
| Europos patento paraiškos padavimo data | 2016-06-29 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-05-09 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2025-03-05 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2016/040134 |
| Data | 2016-06-29 |
| (87) | Numeris | WO 2017/004230 |
| Data | 2017-01-05 |
| (30) | Numeris | Data | Šalis |
| 201562187086 P | 2015-06-30 | US |
| (72) |
BOSCH, Marnix, L. , US
|
| (73) |
NorthWest Biotherapeutics, Inc. ,
4800 Montgomery Lane, Suite 800, Bethesda, MD 20814,
US
|
| (54) | OPTIMALLY ACTIVATED DENDRITIC CELLS THAT INDUCE AN IMPROVED OR INCREASED ANTI-TUMOR IMMUNE RESPONSE |
| OPTIMALLY ACTIVATED DENDRITIC CELLS THAT INDUCE AN IMPROVED OR INCREASED ANTI-TUMOR IMMUNE RESPONSE |